<VariationArchive VariationID="12222" VariationName="NM_000490.5(AVP):c.64_66del (p.Phe22del)" VariationType="Deletion" Accession="VCV000012222" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2018-02-22" MostRecentSubmission="2018-02-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27261" VariationID="12222">
      <GeneList>
        <Gene Symbol="AVP" FullName="arginine vasopressin" GeneID="551" HGNC_ID="HGNC:894" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3082556" stop="3084724" display_start="3082556" display_stop="3084724" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3063201" stop="3065369" display_start="3063201" display_stop="3065369" Strand="-" />
          </Location>
          <OMIM>192340</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000490.5(AVP):c.64_66del (p.Phe22del)</Name>
      <CanonicalSPDI>NC_000020.11:3084608:GAAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3084609" stop="3084611" display_start="3084609" display_stop="3084611" variantLength="3" positionVCF="3084608" referenceAlleleVCF="GGAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3065255" stop="3065257" display_start="3065255" display_stop="3065257" variantLength="3" positionVCF="3065254" referenceAlleleVCF="GGAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F22del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.3065256_3065258del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.3065256_3065258del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.3084610_3084612del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.3084610_3084612del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008663.1" sequenceAccession="NG_008663" sequenceVersion="1" change="g.5114_5116del">
            <Expression>NG_008663.1:g.5114_5116del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000490.5" sequenceAccession="NM_000490" sequenceVersion="5" change="c.64_66del" MANESelect="true">
            <Expression>NM_000490.5:c.64_66del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000481.2" sequenceAccession="NP_000481" sequenceVersion="2" change="p.Phe22del">
            <Expression>NP_000481.2:p.Phe22del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_715" sequenceAccession="LRG_715">
            <Expression>LRG_715:g.5114_5116del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_715t1" sequenceAccession="LRG_715t1">
            <Expression>LRG_715t1:c.64_66del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="192340.0020" DB="OMIM" />
        <XRef Type="rs" ID="2148571804" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 192340.0020 from the sequence reported in Figure 2 of the paper by Wahlstrom et al., 2004 (PubMed 15070970).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000490.5(AVP):c.64_66del (p.Phe22del) AND Neurohypophyseal diabetes insipidus" Accession="RCV000013006" Version="17">
        <ClassifiedConditionList TraitSetID="8098">
          <ClassifiedCondition DB="MedGen" ID="C0342394">Neurohypophyseal diabetes insipidus</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-02-22" MostRecentSubmission="2018-02-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15070970</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8098" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6476" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DIABETES INSIPIDUS, PRIMARY CENTRAL</ElementValue>
                <XRef Type="MIM" ID="125700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurohypophyseal diabetes insipidus</ElementValue>
                <XRef ID="Neurogenic+diabetes+insipidus/5185" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007450" DB="MONDO" />
                <XRef ID="45369008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pituitary diabetes insipidus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes insipidus cranial type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes Insipidus, Neurogenic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary arginine vasopressin deficiency</ElementValue>
                <XRef ID="30925" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CDI</ElementValue>
                <XRef Type="MIM" ID="125700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6015" />
                <XRef ID="6015" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16629" />
                <XRef ID="16629" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/ng19</URL>
                <CitationText>UK NICE Guideline NG19, Diabetic foot problems: prevention and management, 2019</CitationText>
              </Citation>
              <XRef ID="178029" DB="Orphanet" />
              <XRef ID="30925" DB="Orphanet" />
              <XRef ID="C0342394" DB="MedGen" />
              <XRef ID="MONDO:0007450" DB="MONDO" />
              <XRef Type="MIM" ID="125700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33251" SubmissionDate="2018-02-19" DateLastUpdated="2018-02-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="192340.0020_DIABETES INSIPIDUS, NEUROHYPOPHYSEAL" title="AVP, 3-BP DEL, PHE3DEL_DIABETES INSIPIDUS, NEUROHYPOPHYSEAL" />
        <ClinVarAccession Accession="SCV000033251" DateUpdated="2018-02-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an American kindred with autosomal dominant neurohypophyseal diabetes insipidus (125700), Wahlstrom et al. (2004) identified deletion of 3 nucleotides in exon 1 of the AVP gene, either CTT or TTC, resulting in deletion of the phenylalanine at codon 3 (F3del). The index patient was a 78-year-old man noted to have hypotonic polyuria after a surgical procedure. He had experienced polyuria and polydipsia since childhood but had avoided medical attention by assiduously maintaining access to water at all times. His family had recognized that some members required large volumes of water, and to accommodate these individuals (known in the family as 'water dogs'), a number of extra wells had been dug on the family farm. Neuro 2A cells stably transfected with the mutant AVP-NP construct showed increased rates of apoptosis as assessed by flow cytometric methods. These observations supported the concept that cellular toxicity of abnormal AVP-NP gene products underlies the development of ADNDI, and the data further demonstrated that mutations affecting the AVP moiety can result in initiation of these pathologic processes.</Attribute>
              <Citation>
                <ID Source="PubMed">15070970</ID>
              </Citation>
              <XRef DB="OMIM" ID="125700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AVP" />
          </GeneList>
          <Name>AVP, 3-BP DEL, PHE3DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, PHE3DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="192340.0020" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DIABETES INSIPIDUS, NEUROHYPOPHYSEAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33251" TraitType="Disease" MappingType="Name" MappingValue="DIABETES INSIPIDUS, NEUROHYPOPHYSEAL" MappingRef="Preferred">
        <MedGen CUI="C0342394" Name="Neurohypophyseal diabetes insipidus" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

